19 November 2024 • 1 minute read
AI’s impact on the life sciences industry and drug development
A CLE webinarTuesday, November 19, 2024
DLA Piper hosted a webinar that explored AI’s impact on drug development and the life sciences industry.
Partners Susan Krumplitsch, Ellen Scordino, and Danny Tobey discussed:
- Challenges and opportunities in patenting AI-related inventions
- AI’s role in disease identification and diagnosis, drug discovery, personalized medicine, and clinical trials
- Intellectual property protections when AI is part of your development story
CLE credit was offered for this event.
For more information
Please contact Ryan King.